Bad news for academic freedom, but it might enable

Quote:

---

Bad news for academic freedom, but it might enable the Alz trial to begin now that Cornell federal funds will no longer be frozen.

---

Per the company:

Quote:

---

As previously noted, this study has been funded by an outside foundation to whom we are very grateful, but that wishes to remain anonymous at this time.

---

Clinical trials dot gov may be totally behind in updates due the shutdown, including refreshing our mCRC trial data; it's possible the AD trial info may be awaiting vetting and posting.

Or not.

I have no clue WTAF is going on behind the scenes, and the company doesn't respond to requests for info either, in spite of them urging us to use official channels for questions.

Where's the Cornell AD info?
Update on enrollment and DSMB review at mCRC trial?
FDA meeting happen? Was it even scheduled?
How many sites are recruiting?
Any PD-L1 data available from early participants at 350 ml dosing?

With a vote tally coming up next week you'd think they'd sprinkle a little sugar in our direction.

Grrrrrrrrr!